Physician

Thomas G Ward, D.O.

According to 2025 Medicare claims, Thomas Ward, D.O. (NPI: 1609892595) practices ophthalmology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 34613-5406.

Ward's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,642 traditional Medicare patients, billed 28,283 HCPCS/CPT codes, and received $5,304,567 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 773 prescription claims across 258 beneficiaries totaling $61,863 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 7 records totaling $355. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,561,599 to $5,304,567. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $32,432 and ending at $61,863. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.7M$5.3M2015 Medicare payment: $1,561,599 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,655,361 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,188,455 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,380,558 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,434,742 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,366,276 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,764,371 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,296,585 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,870,198 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,304,567 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,42014,373$1,561,599
20161,44214,825$1,655,361
20171,88719,077$2,188,455
20181,89518,846$2,380,558
20191,94119,356$2,434,742
20201,83918,391$2,366,276
20211,86919,837$2,764,371
20221,89620,426$3,296,585
20231,81521,904$4,870,198
20241,64228,283$5,304,567

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$79K$158K2015 Drug cost: $32,432 (USD; Tot_Drug_Cst)2016 Drug cost: $27,183 (USD; Tot_Drug_Cst)2017 Drug cost: $46,957 (USD; Tot_Drug_Cst)2018 Drug cost: $75,688 (USD; Tot_Drug_Cst)2019 Drug cost: $86,682 (USD; Tot_Drug_Cst)2020 Drug cost: $80,930 (USD; Tot_Drug_Cst)2021 Drug cost: $48,548 (USD; Tot_Drug_Cst)2022 Drug cost: $158,123 (USD; Tot_Drug_Cst)2023 Drug cost: $85,929 (USD; Tot_Drug_Cst)2024 Drug cost: $61,863 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015143473$32,432
2016152433$27,183
2017223682$46,957
2018247850$75,688
2019260839$86,682
2020261851$80,930
2021239792$48,548
2022268900$158,123
2023276819$85,929
2024258773$61,863

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg5395,948$651
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more309309$129
67028Injection of drug into eye6853,220$104
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,3822,535$70
92134Imaging of retina1,4114,261$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1849,127$7,940
CombiganBrimonidine Tartrate/Timolol16767$5,036
Timolol MaleateTimolol Maleate1468,500$1,810
TravoprostTravoprost12531$1,304
ErythromycinErythromycin Base1001,262$1,087

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$355Penumbra, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas G. Ward, D.O.?

Tedicare shows public-source Medicare data for Thomas G. Ward, D.O. (NPI 1609892595), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas G. Ward, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas G. Ward, D.O.?

Thomas G. Ward, D.O. is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Thomas G. Ward, D.O. have Open Payments data?

Thomas G. Ward, D.O. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.